Menu
Back to Journals » Drug, Healthcare and Patient Safety » Volume 3
Perspectives
Should benefit–risk assessment have its own drug “label”?
| Total article views | Abstract views | HTML views | PDF downloads | Totals | |
|---|---|---|---|---|---|
| 7,722 | Dovepress* | 6,511 | 500+ | 1,630 | 7,011 |
| PubMed Central* | 8 | 703 | 130 | 711 | |
| Totals | 6,519 | 1,203 | 1,760 | 7,722 | |
|
*Since 3 August 2011 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 7 | 0 | 0 | 0 | 3 | 4 |
View citations on PubMed Central and Google Scholar